You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

FROVA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


DrugPatentWatch® Litigation and Generic Entry Outlook for Frova

A generic version of FROVA was approved as frovatriptan succinate by GLENMARK PHARMS LTD on March 11th, 2016.

  Try a Trial

Paragraph IV (Patent) Challenges for FROVA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
FROVA Tablets frovatriptan succinate 2.5 mg 021006 1 2011-03-09

US Patents and Regulatory Information for FROVA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Pharms FROVA frovatriptan succinate TABLET;ORAL 021006-001 Nov 8, 2001 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Mylan FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 202931-001 Aug 28, 2014 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Amneal Pharms Co FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 211292-001 Nov 6, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glenmark Pharms Ltd FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 204730-001 Mar 11, 2016 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Renata FROVATRIPTAN SUCCINATE frovatriptan succinate TABLET;ORAL 213891-001 Apr 6, 2022 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FROVA

International Patents for FROVA

See the table below for patents covering FROVA around the world.

Country Patent Number Title Estimated Expiration
Slovakia 131993 AGONISTS 5 HT-1 RECEPTORS ⤷  Try a Trial
Japan H06508827 ⤷  Try a Trial
Japan 3364222 ⤷  Try a Trial
United Kingdom 9113802 ⤷  Try a Trial
Japan H08504790 ⤷  Try a Trial
China 1034072 ⤷  Try a Trial
Canada 2113726 UTILISATION DE DERIVES TETRAHYDROCARBAZONE COMME AGONISTES DES RECEPTEURS 5HT1 (USE OF TETRAHYDROCARBAZONE DERIVATIVES AS 5HT1 RECEPTOR AGONISTS) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for FROVA

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0591280 C00591280/01 Switzerland ⤷  Try a Trial FORMER REPRESENTANTIVE: E. BLUM AND CO. PATENTANWAELTE, CH
0591280 SPC/GB03/014 United Kingdom ⤷  Try a Trial PRODUCT NAME: 3 METHYLAMINO-6-CARBOXAMIDO-1, 2, 3, 4-TETRAHYDROCARBAZOLE ("FROVATRIPTAN") INCLUDING A SALT, SOLVATE OR HYDRATE THEREOF; REGISTERED: FR NL 24548 20001212; UK PL 16239/0017 20021007; UK PL 16239/0018 20021007
0591280 37/2002 Austria ⤷  Try a Trial PRODUCT NAME: FROVATRIPAN; NAT. REGISTRATION NO/DATE: 1-24487 20020424; FIRST REGISTRATION: FR NL 24548 20001212
0591280 01C0019 France ⤷  Try a Trial PRODUCT NAME: FROVATRIPTAN SUCCINATE MONOHYDRATE; NAT. REGISTRATION NO/DATE: NL 24548 20001212; FIRST REGISTRATION: FR - NL 24548 20001212
0591280 C300103 Netherlands ⤷  Try a Trial PRODUCT NAME: FROVATRIPTAN EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN; NAT. REGISTRATION NO/DATE: RVG 27211RVG 27212 2002190419; FIRST REGISTRATION: NL 24548 20001212
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.